| 2:00 p.m. |
|
Other Tri-Institutional Events
Treating Thalassemia: From Transfusion to Engineered Stem Cells
Michel Sadelain, M.D., Ph.D., director, Gene Transfer and Somatic Cell Engineering Facility, and Stephen and Barbara Friedman Chair, department of molecular pharmacology and chemistry, Memorial Sloan-Kettering Cancer Center Evangelia Yannaki, M.D., George Papanicolaou Hospital, Greece, Stem Cell Mobilization in β-Thalassemic Subjects Farid Boulad, M.D., medical director, Pediatric Day Hospital, Memorial Sloan-Kettering Cancer Center, The Upcoming First U.S. Trial of Globin Gene Transfer
|
